Improving treatment options for brain aneurysms using advanced technology
Computational and Biological Approach to Flow Diversion
This study is looking to improve how we treat unruptured brain aneurysms by creating better devices and understanding how they work, so that patients can have safer and more personalized treatment options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10991372 on NIH RePORTER |
What this research studies
This research aims to enhance the treatment of unruptured intracranial aneurysms by developing advanced flow diversion devices. It focuses on understanding the mechanisms of aneurysm occlusion and the risks associated with thromboembolic complications. By utilizing innovative imaging techniques and computational modeling, the study seeks to customize treatment approaches for individual patients, potentially expanding the use of these devices to more complex cases, including ruptured aneurysms. Patients may benefit from more effective and safer treatment options tailored to their specific conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with unruptured intracranial aneurysms, particularly those who may benefit from advanced flow diversion techniques.
Not a fit: Patients with ruptured aneurysms or those not eligible for flow diversion treatments may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for patients with brain aneurysms, reducing risks and enhancing outcomes.
How similar studies have performed: Previous research has shown promise in using advanced imaging and computational techniques for similar applications, indicating potential for success in this novel approach.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Kadirvel, Ramanathan — Mayo Clinic Rochester
- Study coordinator: Kadirvel, Ramanathan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.